TeamViewer : Q1 2024 Ergebnis

Q1 2024 Results

Analyst / Investor Presentation

Important Notice / APMs

This presentation as well as any information communicated in connection therewith (the "Presentation") contains information regarding TeamViewer SE (the "Company") and its subsidiaries (the Company, together with its subsidiaries, "TeamViewer"). It is provided for information purposes only and should not be relied on for any purpose and may not be redistributed, reproduced, published, or passed on to any other person or used in whole or in part for any other purpose.

Certain statements in this presentation may constitute forward looking statements. These statements are based on assumptions that are believed to be reasonable at the time they are made, and are subject to significant risks and uncertainties, including, but not limited to, those risks and uncertainties described in TeamViewer's disclosures. You should not rely on these forward-looking statements as predictions of future events, and TeamViewer's actual results may differ materially and adversely from any forward-looking statements discussed in these statements due to several factors, including without limitation, risks from macroeconomic developments, external fraud, lack of innovation capabilities, inadequate data security and changes in competition levels. TeamViewer undertakes no obligation, and does not expect to publicly update, or publicly revise, any forward-looking statement, whether as a result of new information, future events or otherwise. All subsequent

written and oral forward-looking statements attributable to it or to persons acting on its behalf are expressly qualified in their entirety by the cautionary statements

referred to above and contained elsewhere in this Presentation.

All stated figures are unaudited.

Percentage change data and totals presented in tables throughout this presentation are generally calculated on unrounded numbers. Therefore, numbers in tables may not add up precisely to the totals indicated and percentage change data may not precisely reflect the change data of the rounded figures for the same reason.

This document contains alternative performance measures (APM) that are not defined under IFRS. The APMs (non-IFRS) can be reconciled to the key performance indicators included in the IFRS consolidated financial statements and should not be viewed in isolation, but only as supplementary information for assessing the operating performance. TeamViewer believes that these APMs provide an additional, deeper understanding of the Company's performance.

TeamViewer has defined each of the following APMs as follows:

• Adjusted EBITDA(also referred to as Adjusted (Revenue) EBITDA) is defined as operating income (EBIT) according to IFRS, plus depreciation and amortization of tangible and intangible fixed assets (EBITDA), adjusted for certain business transactions (income and expense) defined by the Management Board in agreement with the Supervisory Board. Business transactions to be adjusted relate to share-based compensation schemes and other material special items of the business that are presented separately to show the underlying operating performance of the business.
• Adjusted EBITDA margin(also referred to as Adjusted (Revenue) EBITDA Margin) means Adjusted EBITDA as a percentage of revenue.
• Billingsrepresent the value (net) of goods and services invoiced to customers within a specific period and which constitute a contract as defined by IFRS 15.
• Retained Billingsmeans recurring Billings (renewals, up- & cross sell) attributable to retained subscribers who were subscribers in the previous twelve-month period.
• New Billingsmeans recurring Billings attributable to new subscribers.

TeamViewer | Q1 2024 Results	2

Important Notice / APMs (continued)

• Non-recurringBillingsmeans Billings that do not recur, such as professional services and hardware reselling.
• Net Retention Rate (NRR)means the Retained Billings of the last twelve months (LTM), divided by the total recurring Billings (Retained Billings + New Billings) of the previous twelve-month period (LTM-1). The total recurring Billings of the LTM-1 period are adjusted for Multi Year Deals (MYD).
• Annual Recurring Revenue (ARR)are annualized recurring Billings for all active subscriptions at the reporting date.
• Number of subscribersmeans the total number of paying subscribers with a valid subscription at the reporting date.
• SMB customersmean customers with ACV across all products and services of less than EUR 10,000 within the last twelve-month period. If the threshold is exceeded, the customer will be reallocated.
• Enterprise customersmean customers with ACV across all products and services of at least EUR 10,000 within the last twelve-month period. Customers who do not reach this threshold will be reallocated.
• Churn(subscribers) is calculated by dividing the number of retained subscribers at the reporting date by the total number of subscribers at the previous year's reporting date.
• Average Selling Price (ASP)is calculated by dividing the total SMB / Enterprise Billings of the last twelve months (LTM) by the total number of SMB / Enterprise subscribers at the reporting date.
• Annual Contract Value (ACV)is used to distinguish different pricing buckets within SMB and Enterprise. The ACV is defined as the annualized value of one SMB / Enterprise contract.
• Net financial liabilitiesare defined as financial liabilities (without other financial liabilities) less cash and cash equivalents.
• Net leverage ratiomeans the ratio of net financial liabilities to Adjusted EBITDA of the last twelve-month period.
• Levered Free Cash Flow (FCFE)means net cash from operating activities less capital expenditure for property, plant and equipment and intangible assets (excl. M&A), payments for the capital element of lease liabilities and interest paid for borrowings and lease liabilities.
• Cash Conversionmeans the percentage share of Levered Free Cash Flows (FCFE) in relation to the Adjusted EBITDA.
• Adjusted Net Incomeis the net income adjusted for certain income and expenses. These adjustments are: share-based compensation, amortization related to business combinations, other non-recurring income and expenses and related tax effects.
• Adjusted basic earnings per shareis calculated in line with basic earnings per share, whereby Adjusted Net Income is used as the basis for the calculation instead of the net income.

TeamViewer | Q1 2024 Results	3

Business Overview

Oliver Steil (CEO)

Q1 2024 results mark a good start to the year

Highlights

Continued Revenue growth	Adjusted EBITDA Margin of 40%	Strong growth in Billings from
(+9% cc) yoy and ENT Revenue	after additional strategic	new customers (+25% yoy); all-
growth of 19% cc yoy	investments in marketing, sales	time high subscriber numbers in
	and R&D	ENT (~4.2k) and SMB (~636k)

New partnership with	Further improved	FY 2024
Manhattan Associates	maturity profile with	guidance reiterated
strengthening leadership in	successful placement of
vision picking	promissory note

TeamViewer | Q1 2024 Results	5

Continued strong growth in highest value buckets

SMB Billings by ACV Bucket (LTM)

(€m; LTM)			€ 1,500 - 10,000
517.3	535.0		€ 500 - <1,500
		€ <500

237.5257.0

+8%

Net upsell from

SMB to Enterprise:

€14.3m LTM

175.9 -2% 173.1

104.0 +1% 105.0

Enterprise Billings by ACV Bucket (LTM)

(€m; LTM)		>€ 200,000
		>€	100,000
140.7		>€	50,000
130.8		€ 10,000 - 50,000

20.4	+38%	28.2
16.0	+6%	17.0
24.8	-10%	22.5

69.5 +5% 73.0

Q1 2023Q1 2024Q1 2023Q1 2024

TeamViewer | Q1 2024 Results	6

Revenue growth across all regions and customer categories

Regional Development	Customer Categories
(% yoy)	(% yoy)

		AMERICAS
		Revenue:
		€55.1m (+2% | 6% cc)
EMEA	€161.7m	ENT	€161.7m	SMB
Revenue:	(+7% | 9% cc)	Revenue:	(+7% | 9% cc)	Revenue:
€88.6m (+11% | 11% cc)		€33.7m (+17% | 19% cc)		€128.0m (+5% | 7% cc)

APAC

Revenue: €18.0m (+2% | 10% cc)

TeamViewer | Q1 2024 Results	7

Very attractive new logo wins and use cases

FRONTLINE

TENSOR

• Provider of health and age care services across Australia
• Remote AR-based assistance expanded the ability to address clinical issues and break through geographical barriers
• Remarkable reduction in hospital admissions
• Reduced referral wait times from
  1-2 weeks to 1-2 days, response time up 75%
• Travel cost avoidance and generated savings led to cost neutral investment

• Real-timeremote monitoring of EEG patient data as a service, based on TeamViewer
• Integris can expand its business geographically and hire the best talent from coast to coast
• Hospitals save cost and time and can alleviate nursing staff shortage
• Compliance with HIPAA standards safeguards sensitive patient data

TeamViewer | Q1 2024 Results	8

Financial Overview

Michael Wilkens (CFO)

Q1 2024 results mark a good start to the year

Topline KPIs Q1 2024

(% and pp yoy)

Profitability / Cash Q1 2024

(% and pp yoy)

Revenue

Billings

ARR (LTM)

NRR (LTM)

€161.7m1

+7%/+9% cc

€174.5m

-1%/-1% cc

€656.9m

+7%

103%

-4pp

Adjusted EBITDA	€65.2m
+2%
Adjusted EBITDA	40%
Margin	-2pp
Free Cash Flow	€40.5m
(FCFE)	-21%
Adjusted EPS	€0.22
+3%

1 Corresponds to €161.6m Revenue based on average guided FX rates.

TeamViewer | Q1 2024 Results	10